MedPath

The Effects of Auriculotherapy in Women With Breast Cancer During Chemotherapy Treatment

Not Applicable
Recruiting
Conditions
Women
Breast neoplasms
C04.588.180
M01.975
Registration Number
RBR-36zcfg
Lead Sponsor
Hospital de Clinicas da Universidade Federal do Paraná
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

Women; Diagnosis of breast cancer; Chemotherapy treatment; Age between 18 and 99 years

Exclusion Criteria

Using anxiolytics; Antidepressants; Pregnant women

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Based on previous studies (CREW et al, 2007), it is expected that 60% of the patients participating in the study will show improvement in cancer-related symptoms and chemotherapy treatment and consequent improvement in Quality of Life measured by the Quality Assessment Questionnaire called EORT-QLQ-30 (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire) version 3.0.
Secondary Outcome Measures
NameTimeMethod
Based on the same study mentioned above, it is expected an improvement in social well-being of 10%, an improvement of the emotional function of 40% and functional function of 20%, measured by the Quality of Life evaluation questionnaire called EORT-QLQ-30 (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire) version 3.0.<br>
© Copyright 2025. All Rights Reserved by MedPath